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CLINICAL PRACTICE
Investigation of Anaemia
Undervalued investigations for diagnosed
anaemia include a reticulocyte count and
RPI (a correction of the reticulocyte
count in proportion to the anaemia).
This provides a clear differential bet-
WEen marrow suppression/failure and
peripheral loss/consumption, thus en-
abling the clinician to direct
further investigation to either
peripheral causes (haemo-
lysis and blood loss) or to-
wards looking for causes
of haemopoietic suppres-
sion/ failure. If the latter
is suspected, then a bone
marrow aspirate and trephine
is an essential part of the investi-
gation, as this provides infor-
mation regarding the cellular-
ity, relativE representation of
various haematopoietic lines and
the presence of any disorder. This will
indicate substrate deficiency (vitamin
B., or folate). In addition, Pearl's stain
of the marrow gives an accurate assess-
ment of iron stores and clearly differen-
tiates between ACO and iron deficiency, without the
confusion that may arise with biochemical assessment of





HIV has become the major health problem in sOl/them Africa. The manifestations of this
disease affect even) aspect of clinical practice, and the protean symptomatologJ) of HIV
infection and AIDS makes a sOl/nd approach to the diagnosis of common problems essential.
The environment of cost containment within which medical practitioners are required to care
for their patients necessitates a thorough understanding of the patJlOlogJ) of these clinical
problems in order to facilitate accurate and appropriate diagnosis and therapy.
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Haematological problems manifest in almost every AIDS patient.' The most serious
complications are the cytopenias, immune deregulation and haematological malignancies.
Anaemia of chronic disorders
The majority of HIV-related
anaemia is anaemia of chronic
disease (ACO). This is not
usually related to uncontrolied
HI V infection per se and pre-
sents with isolated anaemia.
The majority of patients with
AC 0 have an associated
chronic inflammatory con-
dition. The hallmarks of ACO
are mild to moderate anaemia
(haemoglobin (Hbl B - 12
g/dl', normocytosis to mild
microcytosis (rarely mean
corpuscular volume (MCVl
< 74 fl', an inadequate reticu-
locyte response (normal reticu-
locyte production index (RPIl 1 - 2%), increased iron
stores and raised inflammatory markers. This picture
should alert the physician to actively exclude an underlying
chronic infection such as tuberculosis <TB), MAl, etc.
Ninety per cent of patients with
AIDS will become anaemic at
some point in their illness ..
Persistent anaemia is predic-
tive of a poor outcome. There-
fore, identifying the cause of
the anaemia is essential for
effective management.
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Nutritional anaemia
Haematopoiesis is a sensitive, integrated system of pro-
genitor cells, cytokine support and adequate substrate.
Although folate deficiency is rare, low levels of vitamin
B" are not infrequent. The majority of mild to moder-
ate deficiencies noo - 200 units) are not clinically
significant (assessed using homocysteine levels), The low
cost and rare side-effects of intramuscular vitamin B"
make a trial of therapy an acceptable alternative to
extensive investigation. Remember that vitamin B12
deficiency is often associated with chronic parasitic
infections, e.g. giardiasis and amoebiasis, and with ileal
dysfunction.
BONE MARROW SUPPRESSION
Marrow suppression may be due to extensive infiltration
by TB, but is more commonly related to cytomegalovirus
(CMV) reactivation, uncontrolled HIV infection and
malignant infiltration. Numerous studies have failed to
show any direct toxic effect of HIV on progenitor cells
and yet there is ample evidence of impaired haemopoietic
reserve in vitro and in vivo. This is due largely to a
distorted cytokine milieu, infection of bone marrow
stromal cells and microvascular endotheial cells
(MVECs) by HIV. These cells are universally infected
with HIV and have impaired ability to support progenitor
cells from non-H IV-infected individuals.' Infected
individuals have decreased levels of IL4, G-CSF and GM-
CSF which contributes to their poor haemopoietic
reserve.J
THROMBOCYTOPENIA
Impaired haematopoiesis on the basis of HIV infection
tends to cause suppression of thrombopoiesis and
granulopoiesis. In addition, these findings are associated
with more advanced HIV. In fact a leukocyte count of
< 2 is strongly predictive (PPV = 90%) of a CD4 count
of less than 200 x 10'/1. Thrombocytopenia is a common
feature of advanced AIDS and tends to be mild to
moderate (platelet count> 80 x 10'/1). This is usually
associated with anaemia and leucopenia.
Immune thrombocytopenia, on the other hand, is
usually an isolated feature of earlier HIV infection (i.e.
Hb and white cell count are normall. It is manifested in
the early phase of immune deregulation during polyclonal
B-cell expansion and polyclonal hyper-gammagiobuli-
naemia. Its management is similar to that in non-HIV-
infected patients, using immunosuppressive doses of
steroids. However, the underlying cause is HIV, and once
this is controlled the thrombocytopenia usually resolves.
Peripheral platelet destruction is also associated with
disseminated intravascular coagulopathy <DIC) and
thrombotic thrombocytopenic purpura <TTP). TTP is a
feature of advanced AIDS. It presents with the triad of
thrombocytopenia, thromboses (often cerebral) and
purpuric bleeding. Examination of the peripheral blood
smear shows extensive red cell fragmentation. DIC
is usually associated with underlying infection or
malignancy, especially Karposi's sarcoma.
Diagnosis is usually made late when there is clinical
bleeding, organ failure, thrombocytopenia, prolonged
aPTT, low antithrombin level and raised D-dimers.
Management is difficult, with a high mortality rate if the
underlying precipitant is not controlled.
LYMPHOMA
Non-Hodgkin's lymphoma is the most common haema-
tological malignancy associated with HIV and has a
number of aetiological factors. Low-grade lymphoma
presents an increased risk, 14 times that of the general
population, but intermediate to high-grade non-Hodgkin's
lymphoma is nearly 350 times more common in HIV-
infected individuals!' The transformation to lymphoma is
associated with longer periods of HIV infection, meaning
that the risk increases the ionger the patient has HIV.
Diffuse large B-cell lymphoma <DLCU is associated
with immune suppression due to other causes, e.g. post-
renal transplant, and in this scenario is almost always
Epstein-Barr virus (EBVl-associated. However, in HIV,
approximately half the patients are EBV-negative,
indicating other mechanisms of lymphoma genesis.' This
may be related to cytokine deregulation and infection of
stromal cellslMVECs by HIV. Infected MVECs sustain
lymphoma cells in culture better than uninfected stromal
cells. This may, at least in part, explain the high incidence
of extranodal and primary central nervous system
(CNS) lymphomas. In addition, oncogenic viruses such
as HHV-8 have been causally linked to primary effusion
lymphomas (body cavity-based lymphomas),'
Management of HIV-associated lymphomas requires
control of the HIV infection. This is a prerequisite as not
only is the infection and immune deregulation causally
linked to the lymphomas, but the suppressive effects of
the virus on haemopoietic reserve and recovery prevent
optimal chemotherapy dose intensity. Maintaining dose
intensity strongly correlates with outcome.
CONCLUSION
In conclusion, the investigation and management of the
haematological manifestations of HIV require a rational
approach and a few simple investigations (start with an
FBC, smear and reticulocyte count), The most common
problem would be ACD, associated with treatable causes
such as TB. Other causes such as myelosuppression related
to antiviral drugs, CMV infection, malignant infiltration,
etc. can be diagnosed with bone marrow aspiration,
serological investigation and by the clinical picture.
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